Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. CNC
stocks logo

CNC

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
48.58B
+19.05%
-1.106
-238.28%
49.13B
+5.39%
2.286
-21.16%
48.67B
-0.14%
0.816
-610%
Estimates Revision
The market is revising Upward the revenue expectations for Centene Corporation (CNC) for FY2025, with the revenue forecasts being adjusted by 1.08% over the past three months. During the same period, the stock price has changed by 48.75%.
Revenue Estimates for FY2025
Revise Upward
up Image
+1.08%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+15.03%
In Past 3 Month
Stock Price
Go Up
up Image
+48.75%
In Past 3 Month
Wall Street analysts forecast CNC stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CNC is 36.90 USD with a low forecast of 30.00 USD and a high forecast of 42.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
12 Analyst Rating
Wall Street analysts forecast CNC stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CNC is 36.90 USD with a low forecast of 30.00 USD and a high forecast of 42.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
8 Hold
2 Sell
Hold
Current: 37.560
sliders
Low
30.00
Averages
36.90
High
42.00
Current: 37.560
sliders
Low
30.00
Averages
36.90
High
42.00
Barclays
Andrew Mok
Equal Weight
maintain
$35 -> $44
2025-11-04
New
Reason
Barclays
Andrew Mok
Price Target
$35 -> $44
2025-11-04
New
maintain
Equal Weight
Reason
Barclays analyst Andrew Mok raised the firm's price target on Centene to $44 from $35 and keeps an Equal Weight rating on the shares following the Q3 report. The company's 2025 Medicaid margins are ending the year higher, helped by actions in Florida and New York, but Centene no longer expects 2026 margin improvement, the analyst tells investors in a research note.
Goldman Sachs
Sell
maintain
$33 -> $38
2025-10-31
Reason
Goldman Sachs
Price Target
$33 -> $38
2025-10-31
maintain
Sell
Reason
Goldman Sachs raised the firm's price target on Centene to $38 from $33 and keeps a Sell rating on the shares.
TD Cowen
Ryan Langston
Hold
maintain
$30 -> $34
2025-10-31
Reason
TD Cowen
Ryan Langston
Price Target
$30 -> $34
2025-10-31
maintain
Hold
Reason
TD Cowen analyst Ryan Langston raised the firm's price target on Centene to $34 from $30 and keeps a Hold rating on the shares. The firm said they reported a relatively positive 3Q25 with EPS +50c vs -14c consensus. MDCD MLR benefited from a +40bps MDCD retro rate adj in Florida.
Oppenheimer
Michael Wiederhorn
Outperform
maintain
$43 -> $45
2025-10-30
Reason
Oppenheimer
Michael Wiederhorn
Price Target
$43 -> $45
2025-10-30
maintain
Outperform
Reason
Oppenheimer analyst Michael Wiederhorn raised the firm's price target on Centene to $45 from $43 and keeps an Outperform rating on the shares. The firm notes Centene reported a solid Q3 beat, even after adjusting for some moving parts in the quarter. Management also raised FY2025 EPS guidance by 25c to at least $2.00, but embedded conservatism around the Q3 outperformance.
UBS
Neutral
downgrade
$43 -> $42
2025-10-30
Reason
UBS
Price Target
$43 -> $42
2025-10-30
downgrade
Neutral
Reason
UBS lowered the firm's price target on Centene to $42 from $43 and keeps a Neutral rating on the shares.
Truist
Buy
maintain
$42 -> $45
2025-10-30
Reason
Truist
Price Target
$42 -> $45
2025-10-30
maintain
Buy
Reason
Truist raised the firm's price target on Centene to $45 from $42 and keeps a Buy rating on the shares. The company's Q3 results saw top and bottom-line beats, consolidated health benefits ratio, HBR, that was a bit better, coupled with sequential improvement in Medicaid HBR and upped FY25 guidance, the analyst tells investors in a research note. High-level 2026 commentary was encouraging, with expectations of Medicaid profitability consistent with FY25, the firm added.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Centene Corp (CNC.N) is 15.17, compared to its 5-year average forward P/E of 12.23. For a more detailed relative valuation and DCF analysis to assess Centene Corp 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
12.23
Current PE
15.17
Overvalued PE
15.18
Undervalued PE
9.29

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Overvalued
5Y Average EV/EBITDA
9.73
Current EV/EBITDA
14.80
Overvalued EV/EBITDA
12.30
Undervalued EV/EBITDA
7.17

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.53
Current PS
37.56
Overvalued PS
3.56
Undervalued PS
-2.51
AI Stock Picker
AI Stock Picker

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Financial AI Agent
Financial AI Agent

CNC News & Events

Events Timeline

(ET)
2025-11-06
11:04:25
Centene Plans to Launch Medicare Advantage Plans in 32 States, Including California, by 2026
select
2025-11-03 (ET)
2025-11-03
10:19:38
Ambetter by Health Net to Provide Health Insurance in California Starting 2026
select
2025-10-29 (ET)
2025-10-29
06:44:21
ACA Plan Participants Face Significant Premium Hikes, According to WSJ
select
link
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
7.5
11-08Newsfilter
Carolina Complete Health and Centene Foundation Invest $200,000 to Address Food Insecurity in North Carolina

  • Investment in Food Security: Carolina Complete Health and the Centene Foundation announced a $200,000 investment to combat food insecurity in North Carolina, supporting various food banks and organizations as millions face challenges accessing nutritious meals.

  • Focus on Vulnerable Communities: The initiative aims to assist over 275,000 Medicaid members in North Carolina, reflecting a commitment to addressing health disparities and improving access to healthy food for vulnerable populations.

  • Broader Commitment to Food Access: Centene has invested over $77 million in food security initiatives across multiple states, emphasizing the importance of nutrition in health outcomes and integrating food access with healthcare services.

  • Long-term Goals for Health Equity: The Centene Foundation focuses on removing barriers to wellness in economically challenged communities, aiming to enhance health equity through strategic investments in healthcare, social services, and education.

[object Object]
Preview
5.0
11-07PRnewswire
Ambetter of Illinois Offers Health Insurance in Illinois in 2026

  • New Marketplace Transition: Illinois is transitioning to a state-based health insurance marketplace, Get Covered Illinois, starting Nov. 1, 2025, with Ambetter of Illinois offering affordable coverage options in 25 counties for the 2026 plan year.

  • Comprehensive Coverage Options: Ambetter of Illinois provides a range of health insurance plans that include essential health benefits, mental health services, and additional perks like the Ambetter Perks program, which offers discounts and rewards for healthy behaviors.

  • Convenient Enrollment Process: The Ambetter of Illinois website allows residents to easily compare coverage options, check eligibility for financial subsidies, and enroll in plans using mobile devices, with the ability to save progress during the enrollment process.

  • 24/7 Virtual Care Services: Members have access to virtual care services for various health issues, enabling them to consult licensed providers from home, enhancing convenience and accessibility to healthcare.

[object Object]
Preview
7.5
11-07Newsfilter
Superior HealthPlan and Centene Foundation Invest $400,000 to Address Food Insecurity in Texas

  • Investment in Food Security: Superior HealthPlan and the Centene Foundation announced a $400,000 investment to support nine food banks in Texas, addressing food insecurity exacerbated by disruptions to nutrition assistance programs like SNAP and WIC.

  • Impact on Communities: The funding aims to provide access to nutritious food for families in need, particularly as demand for food assistance rises, with a focus on improving long-term health outcomes for vulnerable populations.

  • Centene's Broader Commitment: This initiative is part of a larger $1.5 million commitment from the Centene Foundation to combat food insecurity across the country, highlighting the importance of access to nutritious food as a key driver of health.

  • Long-term Health Goals: Centene's efforts include various community-based partnerships and programs aimed at integrating food access with healthcare services, reinforcing their mission to transform community health and improve health equity.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Centene Corp (CNC) stock price today?

The current price of CNC is 37.56 USD — it has increased 1.24 % in the last trading day.

arrow icon

What is Centene Corp (CNC)'s business?

Centene Corporation is a healthcare company. The Company provides fully integrated services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. Its segments include Medicaid, Medicare, Commercial and Other. Specifically, the Medicaid segment includes the Temporary Assistance for Needy Families (TANF) program, Medicaid Expansion programs, the Aged, Blind or Disabled (ABD) program, the Children's Health Insurance Program (CHIP), Long-Term Services and Supports (LTSS), Foster Care, Medicare-Medicaid Plans (MMP), which cover beneficiaries who are dually eligible for Medicaid and Medicare and other state-based programs. The Medicare segment includes Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans and Medicare Prescription Drug Plans. The Commercial segment includes the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products.

arrow icon

What is the price predicton of CNC Stock?

Wall Street analysts forecast CNC stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CNC is 36.90 USD with a low forecast of 30.00 USD and a high forecast of 42.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Centene Corp (CNC)'s revenue for the last quarter?

Centene Corp revenue for the last quarter amounts to 49.69B USD, increased 18.24 % YoY.

arrow icon

What is Centene Corp (CNC)'s earnings per share (EPS) for the last quarter?

Centene Corp. EPS for the last quarter amounts to -13.50 USD, decreased -1092.65 % YoY.

arrow icon

What changes have occurred in the market's expectations for Centene Corp (CNC)'s fundamentals?

The market is revising Upward the revenue expectations for Centene Corporation (CNC) for FY2025, with the revenue forecasts being adjusted by 1.08% over the past three months. During the same period, the stock price has changed by 48.75%.
arrow icon

How many employees does Centene Corp (CNC). have?

Centene Corp (CNC) has 60500 emplpoyees as of November 09 2025.

arrow icon

What is Centene Corp (CNC) market cap?

Today CNC has the market capitalization of 18.46B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto Tracker
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free